Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1988 Dec;9:98–100.

Potential applications of salivary steroid immunoassays for investigations of cancer of reproductive tissues.

P F Fottrell 1
PMCID: PMC2149122  PMID: 3076070

Abstract

The potential applications of measuring reproductive steroids in saliva were examined for investigating the basis of the lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Daily salivary progesterone measurements during the menstrual cycle by a rapid cost effective enzyme-immunoassay provided a more accurate method than established procedures for detecting abnormal ovarian function such as luteal phase defects. These abnormalities are common in athletes who have a later menarche, a higher incidence of oligomenorrhoea and amenorrhoea than non-athletes. A control corridor was established of upper and lower limits for normality of daily salivary progesterone values during the complete menstrual cycle in 42 volunteers. It is concluded that salivary steroid assays provide an accurate and non-invasive procedure suitable for long term comparative studies on ovarian steroids in female athletes and non-athletes before and after menarche.

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. E., Maroulis G. B., Marshall J. R. Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Obstet Gynecol. 1974 Oct;44(4):522–525. [PubMed] [Google Scholar]
  2. Bradlow H. L., Hershcopf R. E., Fishman J. F. Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer. Cancer Surv. 1986;5(3):573–583. [PubMed] [Google Scholar]
  3. Bulbrook R. D. Endocrine aspects of breast and prostatic cancer: an overview. Cancer Surv. 1986;5(3):435–445. [PubMed] [Google Scholar]
  4. Bullen B. A., Skrinar G. S., Beitins I. Z., von Mering G., Turnbull B. A., McArthur J. W. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med. 1985 May 23;312(21):1349–1353. doi: 10.1056/NEJM198505233122103. [DOI] [PubMed] [Google Scholar]
  5. Folan J., Gosling J. P., Fottrell P. F. Solid-phase enzymoimmunoassay of estrone in serum. Clin Chem. 1988 Sep;34(9):1843–1846. [PubMed] [Google Scholar]
  6. Frisch R. E., Gotz-Welbergen A. V., McArthur J. W., Albright T., Witschi J., Bullen B., Birnholz J., Reed R. B., Hermann H. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA. 1981 Oct 2;246(14):1559–1563. [PubMed] [Google Scholar]
  7. Frisch R. E., Wyshak G., Albright N. L., Albright T. E., Schiff I., Jones K. P., Witschi J., Shiang E., Koff E., Marguglio M. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer. 1985 Dec;52(6):885–891. doi: 10.1038/bjc.1985.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henderson B. E., Pike M. C., Casagrande J. T. Breast cancer and the oestrogen window hypothesis. Lancet. 1981 Aug 15;2(8242):363–364. doi: 10.1016/s0140-6736(81)90675-9. [DOI] [PubMed] [Google Scholar]
  9. Henderson B. E., Ross R. K., Judd H. L., Krailo M. D., Pike M. C. Do regular ovulatory cycles increase breast cancer risk? Cancer. 1985 Sep 1;56(5):1206–1208. doi: 10.1002/1097-0142(19850901)56:5<1206::aid-cncr2820560541>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  10. Korenman S. G. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet. 1980 Mar 29;1(8170):700–701. [PubMed] [Google Scholar]
  11. Moore J. W., Thomas B. S., Wang D. Y. Endocrine status and the epidemiology and clinical course of breast cancer. Cancer Surv. 1986;5(3):537–559. [PubMed] [Google Scholar]
  12. Tallon D. F., Gosling J. P., Buckley P. M., Dooley M. M., Cleere W. F., O'Dwyer E. M., Fottrell P. F. Direct solid-phase enzyme immunoassay of progesterone in saliva. Clin Chem. 1984 Sep;30(9):1507–1511. [PubMed] [Google Scholar]
  13. Tallon D. F., Gosling J. P., Cleere W. F., Brett M. G., Dooley M. M., Fottrell P. F. Modified direct enzymoimmunoassay for salivary progesterone. Clin Chem. 1985 Dec;31(12):2040–2041. [PubMed] [Google Scholar]
  14. Vihko R. K., Apter D. L. The epidemiology and endocrinology of the menarche in relation to breast cancer. Cancer Surv. 1986;5(3):561–571. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES